Most recently, it has been discovered that conolidine and the above derivatives act to the atypical chemokine receptor three (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to the big range of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger and isn't going to activate a ne… Read More